Mesoblast Heart Failure Cell Therapy Receives Orphan Drug Designation From FDA for Prevention of Gastrointestinal Bleeding in Patients With Left Ventricular Assist Devices

June 24, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search